Vogt-Koyanagi-Harada disease (VKHD): management
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Vogt-Koyanagi-Harada disease (VKHD): management. Retinal swelling, Neurosensory detachment. Fully referenced neurology checklist.
Optical coherence tomography (OCT): features
- Retinal swelling
- Neurosensory detachment
Fluorescein angiography: features
Locked: subscribe to see this section.
Magnetic resonance imaging (MRI) brain: features
Locked: subscribe to see this section.
Cerebrospinal fluid (CSF) analysis: features
Locked: subscribe to see this section.
Treatment
Locked: subscribe to see this section.
References
- Lavezzo MM, Sakata VM, Morita C, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis 2016; 11:29.
- Kurobe R, Hirano Y, Niwa N, et al. Wide-field fluorescein and indocyanine green angiography findings in the eyes with Vogt-Koyanagi-Harada disease. J Ophthalmic Inflamm Infect 2017; 7:16.
- Keles S, Ogul H, Pinar LC, Kantarci M. Teaching neuroimages: cerebral white matter involvement in a patient with Vogt-Koyanagi-Harada syndrome. Neurology 2013; 81:e85-e86.
- Dogan B, Erol MK, Cengiz A. Vogt-Koyanagi-Harada disease following BCG vaccination and tuberculosis. Springerplus 2016; 5:603.
